Annual report pursuant to Section 13 and 15(d)

Supplemental Information to Consolidated Statements of Cash Flows (Detail)

v3.3.1.900
Supplemental Information to Consolidated Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Schedule of Cash Flow, Supplemental [Line Items]      
Cash paid for interest $ 105,155 $ 107,926 $ 116,890
Cash paid for income taxes, net of refunds received 108,435 122,972 136,124
Noncash investing and financing activities:      
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment [1] 2,491 (1,225) (7,325)
Theatre properties and equipment acquired under capital lease 36,544 19,908 69,541
Investment in NCM - receipt of common units (See Note 6) 15,421 8,216 98,797
Dividends accrued on unvested restricted stock unit awards (593) $ (530) (772)
Receipt of promissory note related to sale of investment in a Taiwan joint venture 2,634    
Other Affiliates      
Noncash investing and financing activities:      
Investment in AC JV, LLC (see Note 7)     8,333
Other Affiliates | AC JV, LLC      
Noncash investing and financing activities:      
Investment in AC JV, LLC (see Note 7)     8,333
Issuance of promissory note related to investment in AC JV, LLC (see Note 7)     $ (8,333)
Other Affiliates | Taiwan Joint Venture      
Noncash investing and financing activities:      
Receipt of promissory note related to sale of investment in a Taiwan joint venture $ 2,304    
[1] Additions to theatre properties and equipment included in accounts payable as of December 31, 2014 and 2015 were $13,235 and $10,744, respectively.